Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES |
|---|---|
| Recipient Organization | Mitchell Group Inc |
| Country | United States |
| Start Date | Jan 22, 2021 |
| End Date | Jan 21, 2022 |
| Duration | 364 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10505916 |
This funding supports core clinical research infrastructure to facilitate multicenter, randomized, controlled clinical trials on Ebola virus, HIV, Malaria, and other infectious diseases in Guinea.
Mitchell Group Inc
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant